DAKLINZA

Marca svizra · 648814 · Marca da pled · Stizzada

Inscripziun en il register

Numer da registraziun
648814
Numer da la dumonda
56858/2013
Status
Stizzada
Tip
Marca da pled
Deponida
07-06-2013
Registrada
20-09-2013
Publitgada
20-09-2013
Stizzada
05-01-2024
Motiv
Betg prolungada
Prioritad
08.03.2013 US
Lingua da la procedura
tudestg
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Pharmazeutische Präparate für den Humangebrauch.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 05-01-2024

    Stritgà, betg prolungà

    Published in Swissreg on 05.01.2024

  2. 18-12-2023

    Adressa dal represchentant midada

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 18.12.2023

  3. 01-02-2021

    Adressa dal possessur midada

    Owner
    Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen → Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16, 6312 Steinhausen

    Published in Swissreg on 01.02.2021

  4. 15-06-2015

    Transferì

    Owner
    Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA → Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen

    Published in Swissreg on 15.06.2015

  5. 20-09-2013

    Registrà

    Published in Swissreg on 20.09.2013

Partidas

Possessura

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Hinterbergstrasse 16, 6312 Steinhausen

Represententa

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.